Ebola cases linked to the Bundibugyo virus strain have exceeded 600 across the Democratic Republic of Congo and Uganda, with health authorities reporting 608 confirmed infections and 102 deaths as of early June. The case fatality rate stands at approximately 16.7 percent, consistent with historical patterns for this less common variant.
The outbreak, concentrated in eastern DRC’s Ituri Province with secondary spread to North and South Kivu, was declared a Public Health Emergency of International Concern by the World Health Organization in mid-May. Unlike the Zaire strain, Bundibugyo currently has no licensed vaccine or targeted therapeutic, complicating containment efforts.
Response operations face significant constraints. Health facilities in affected zones report shortages of potable water, medical waste incinerators, personal protective equipment, and decontamination supplies. Insecurity, limited ambulance capacity, and poor road networks hinder access to remote communities. Staffing pressures and gaps in community trust have further slowed contact tracing and safe burial protocols.
International support is scaling up. On June 5, the Africa Centers for Disease Control and Prevention and WHO jointly launched a continental preparedness and response plan seeking $518 million to strengthen surveillance, diagnostics, and cross-border coordination through November. The United States has mobilized more than $600 million in total assistance as of early June, including over $200 million in bilateral foreign assistance for frontline response activities, $50 million allocated to UN humanitarian channels for establishing Ebola treatment clinics, and approximately $350 million through pooled funds supporting broader stabilization efforts across the affected region. Additional contributions include emergency allocations from the United Nations and medical supplies from the European Union.
While some countries have introduced travel restrictions for affected regions, WHO and Africa CDC have cautioned that such measures may reduce transparency and impede rapid response. The global risk assessment remains low, but the risk level for DRC is classified as very high due to ongoing transmission and population mobility.
Health teams continue to prioritize early detection, isolation, and supportive care. WHO Director-General Tedros Adhanom Ghebreyesus noted that while response capacity is expanding, the virus gained an initial advantage in spread. Authorities urge communities to report symptoms promptly and emphasize that timely clinical support significantly improves survival outcomes.